Guardion Health Sciences, Inc. (GHSI)

USD 3.22

(0.0%)

Total Liabilities Summary of Guardion Health Sciences, Inc.

  • Guardion Health Sciences, Inc.'s latest annual total liabilities in 2023 was 3.77 Million USD , down -55.72% from previous year.
  • Guardion Health Sciences, Inc.'s latest quarterly total liabilities in 2024 Q1 was 6.99 Million USD , up 85.38% from previous quarter.
  • Guardion Health Sciences, Inc. reported annual total liabilities of 8.51 Million USD in 2022, up 632.52% from previous year.
  • Guardion Health Sciences, Inc. reported annual total liabilities of 1.16 Million USD in 2021, down -13.58% from previous year.
  • Guardion Health Sciences, Inc. reported quarterly total liabilities of 1.54 Million USD for 2024 Q2, down -77.85% from previous quarter.
  • Guardion Health Sciences, Inc. reported quarterly total liabilities of 3.77 Million USD for 2023 Q4, down -27.12% from previous quarter.

Annual Total Liabilities Chart of Guardion Health Sciences, Inc. (2023 - 2013)

Historical Annual Total Liabilities of Guardion Health Sciences, Inc. (2023 - 2013)

Year Total Liabilities Total Liabilities Growth
2023 3.77 Million USD -55.72%
2022 8.51 Million USD 632.52%
2021 1.16 Million USD -13.58%
2020 1.34 Million USD 59.25%
2019 844.98 Thousand USD 70.59%
2018 495.33 Thousand USD -0.92%
2017 499.94 Thousand USD -17.72%
2016 607.61 Thousand USD -58.76%
2015 1.47 Million USD -29.39%
2014 2.08 Million USD 52.88%
2013 1.36 Million USD 0.0%

Peer Total Liabilities Comparison of Guardion Health Sciences, Inc.

Name Total Liabilities Total Liabilities Difference
Collegium Pharmaceutical, Inc. 947.87 Million USD 99.602%
Embecta Corp. 2.03 Billion USD 99.815%
ANI Pharmaceuticals, Inc. 471.67 Million USD 99.2%
Dynavax Technologies Corporation 375.02 Million USD 98.994%
Esperion Therapeutics, Inc. 660.79 Million USD 99.429%
Pacira BioSciences, Inc. 704.25 Million USD 99.464%
PainReform Ltd. 2.69 Million USD -40.176%
Aquestive Therapeutics, Inc. 163.9 Million USD 97.699%
Sunshine Biopharma, Inc. 6.13 Million USD 38.561%
SCYNEXIS, Inc. 55.45 Million USD 93.197%
China SXT Pharmaceuticals, Inc. 9.19 Million USD 58.983%
Cosmos Health Inc. 30.25 Million USD 87.531%
Journey Medical Corporation 56.49 Million USD 93.324%
Sunshine Biopharma, Inc. 6.13 Million USD 38.561%
Safety Shot Inc 3.89 Million USD 3.081%
Alpha Teknova, Inc. 38.55 Million USD 90.215%
Intra-Cellular Therapies, Inc. 136.87 Million USD 97.244%
Bright Green Corporation 6.43 Million USD 41.409%
Procaps Group, S.A. 462.06 Million USD 99.184%
Theratechnologies Inc. 98.63 Million USD 96.176%
Harrow Health, Inc. 241.75 Million USD 98.44%
Sonoma Pharmaceuticals, Inc. 8.75 Million USD 56.919%
Biofrontera Inc. 23.13 Million USD 83.698%
DURECT Corporation 30.4 Million USD 87.594%
Supernus Pharmaceuticals, Inc. 487.46 Million USD 99.226%
Cronos Group Inc. 43.73 Million USD 91.375%
OptiNose, Inc. 194.33 Million USD 98.059%
Ironwood Pharmaceuticals, Inc. 817.36 Million USD 99.539%
Kala Pharmaceuticals, Inc. 48.44 Million USD 92.214%
RedHill Biopharma Ltd. 20.97 Million USD 82.019%
Organogenesis Holdings Inc. 181.36 Million USD 97.92%
Cumberland Pharmaceuticals Inc. 52.51 Million USD 92.817%
Radius Health, Inc. 804.29 Million USD 99.531%
Universe Pharmaceuticals INC 13.75 Million USD 72.575%
ProPhase Labs, Inc. 42.54 Million USD 91.134%
Phibro Animal Health Corporation 725.54 Million USD 99.48%
Procaps Group S.A. 462.06 Million USD 99.184%
Alvotech 1.88 Billion USD 99.8%
TherapeuticsMD, Inc. 14.02 Million USD 73.098%
Viatris Inc. 27.21 Billion USD 99.986%
Rockwell Medical, Inc. 30.88 Million USD 87.785%
Aytu BioPharma, Inc. 90.37 Million USD 95.826%
SIGA Technologies, Inc. 57.97 Million USD 93.494%
Tilray Brands, Inc. 892.11 Million USD 99.577%
Lifecore Biomedical, Inc. 219.8 Million USD 98.284%
Shineco, Inc. 47.6 Million USD 92.076%
PetIQ, Inc. 645.22 Million USD 99.415%
Regencell Bioscience Holdings Limited 219.51 Thousand USD -1618.418%
Incannex Healthcare Limited 5.83 Million USD 35.298%
Neurocrine Biosciences, Inc. 1.01 Billion USD 99.63%
Alimera Sciences, Inc. 107.35 Million USD 96.486%
Silver Spike Investment Corp. 3 Million USD -25.327%
Assertio Holdings, Inc. 148.41 Million USD 97.458%
Shuttle Pharmaceuticals Holdings, Inc. 1.89 Million USD -98.956%
Petros Pharmaceuticals, Inc. 21.31 Million USD 82.304%
Clever Leaves Holdings Inc. 7.02 Million USD 46.312%
Cyclo Therapeutics, Inc. 8.49 Million USD 55.572%
Avadel Pharmaceuticals plc 173.38 Million USD 97.824%
Hempacco Co., Inc. 18.82 Million USD 79.959%
Talphera, Inc. 6.29 Million USD 40.03%
Alvotech 1.88 Billion USD 99.8%
Eagle Pharmaceuticals, Inc. 172.6 Million USD 97.815%
Lantheus Holdings, Inc. 835.25 Million USD 99.548%
Currenc Group, Inc. 177.67 Million USD 97.877%
Kamada Ltd. 109.96 Million USD 96.57%
Indivior PLC 1.95 Billion USD 99.807%
Evoke Pharma, Inc. 9.64 Million USD 60.903%
Flora Growth Corp. 17.22 Million USD 78.097%
Cyclo Therapeutics, Inc. 8.49 Million USD 55.572%
Evolus, Inc. 209.68 Million USD 98.201%
HUTCHMED (China) Limited 536.38 Million USD 99.297%
Amphastar Pharmaceuticals, Inc. 873.49 Million USD 99.568%
Akanda Corp. 12.66 Million USD 70.225%